|
| (-)-8-[(S)-2,3-Dihydroxy-3-methylbutyl]-7-methoxy-2H-1-benzopyran-2-one Basic information |
Product Name: | (-)-8-[(S)-2,3-Dihydroxy-3-methylbutyl]-7-methoxy-2H-1-benzopyran-2-one | Synonyms: | (-)-8-[(S)-2,3-Dihydroxy-3-methylbutyl]-7-methoxy-2H-1-benzopyran-2-one;(-)-Merancin hydrate;(-)-Meranzin hydrate;Merancin hydrate;Meranzin hydrate;Merancin hyrate;2H-1-Benzopyran-2-one, 8-[(2S)-2,3-dihydroxy-3-methylbutyl]-7-methoxy-;(-)-8-[(S)-2,3-Dihydroxy-3-methylbutyl]-7-methoxy-2H-1-benzopyran-2-one | CAS: | 5875-49-0 | MF: | C15H18O5 | MW: | 278.3 | EINECS: | | Product Categories: | | Mol File: | 5875-49-0.mol | |
| (-)-8-[(S)-2,3-Dihydroxy-3-methylbutyl]-7-methoxy-2H-1-benzopyran-2-one Chemical Properties |
Melting point | 130-131 °C(Solv: ethyl ether (60-29-7)) | Boiling point | 500.5±50.0 °C(Predicted) | density | 1.271±0.06 g/cm3(Predicted) | storage temp. | -20°C | solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | pka | 14.46±0.20(Predicted) | form | Powder | LogP | 0.610 (est) |
Hazard Codes | N | Risk Statements | 50 | Safety Statements | 61 | RIDADR | UN 3077 9 / PGIII | WGK Germany | 3 |
| (-)-8-[(S)-2,3-Dihydroxy-3-methylbutyl]-7-methoxy-2H-1-benzopyran-2-one Usage And Synthesis |
target | Adrenergic Receptor | ERK |
| (-)-8-[(S)-2,3-Dihydroxy-3-methylbutyl]-7-methoxy-2H-1-benzopyran-2-one Preparation Products And Raw materials |
|